Navigation Links
Abbott Named One of the 'Top Employers' in the Biotech and Pharmaceutical Industry by Science Magazine
Date:10/7/2010

d-research-list">Surveys, Polls and Research Click to view news release full screen  

Abbott Named One of the 'Top Employers' in the Biotech and Pharmaceutical Industry by Science Magazine

 

ABBOTT PARK, Ill., Oct. 7 /PRNewswire/ -- Abbott (NYSE: ABT) today was named one of the top 20 employers in Science magazine's 2010 Top Biopharma Employers survey.  The annual survey seeks to identify the companies with the best reputations as employers.  According to the survey, Abbott's top three driving characteristics were: clear vision, loyal employees, and does important, quality research. The complete rankings are available online and in the Oct. 8, 2010 issue of Science.

"At Abbott, science is the foundation of our success and every day thousands of Abbott scientists work to find meaningful solutions for patients around the world," said John Leonard, M.D., senior vice president, pharmaceuticals, research and development, Abbott and chair of Abbott's scientific governing board.  "Abbott is proud to be included on Science magazine's list of top employers.  The ranking is further evidence that we have been successful in our effort to create a creative, collaborative scientific organization that encourages and rewards innovative thinking."

At Abbott, all employees are given opportunities to succeed, lead and grow in their careers through training, mentoring, networking groups and extensive development programs.  Abbott scientists are rewarded through the Chairman's awards, Pres
'/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Abbott Receives FDA Market Clearance for Next-Generation Contact Lens Disinfecting Solution
2. Abbotts XIENCE V® Shows Continued Strong Performance in Key Safety and Efficacy Measures at Two Years in Investigator-Initiated COMPARE Trial
3. Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Bardoxolone Methyl for Chronic Kidney Disease Outside the U.S.
4. Abbotts Fully Bioresorbable Vascular Scaffold Technology Continues to Demonstrate Strong Clinical Results
5. The Deal Names Abbott Top Dealmaker for Third Consecutive Year
6. Abbott Declares 347th Consecutive Quarterly Dividend
7. Abbott to Present Data on Market-Leading XIENCE V® and Promising Vascular Pipeline at TCT 2010
8. Abbott Statement on the FDA Advisory Committee Recommendation on Sibutramine
9. Abbott Honored for Workplace Leadership for the Tenth Consecutive Year by Working Mother Magazine
10. Abbott Included on the Dow Jones Sustainability Indexes for Six Consecutive Years in Recognition of Leading Corporate Citizenship Performance
11. Abbott Completes Acquisition of Piramals Healthcare Solutions Business, Becomes Leading Pharmaceutical Company in India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015 /PRNewswire/-- Harwood Feffer LLP ( ... of directors of Advaxis, Inc. ("Advaxis" or the "Company") ... has breached its fiduciary duties to shareholders. ... an investing website reporting that Advaxis had misrepresented the ...
(Date:1/23/2015)... Jan. 23, 2015  HyGreen, Inc., a leader in hand ... with RCA Medical, a subsidiary of Ascendis Health Limited, ... Each year, hundreds of millions of patients around ... organisms are transmitted from patient to patient via the ...
(Date:1/23/2015)... , Jan. 23, 2015  iMD Companies, Inc. (ICBU) has ... increase market share and grab a foothold in the hydroponic, ... production capabilities and a presence in the sector, and recently ... the growth of hemp and medical marijuana, iMD is committing ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2HyGreen Partners with RCA Medical in Johannesburg, South Africa 2iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2
... prGCD treatment of Gaucher Disease, CARMIEL, Israel, Aug. ... announced that it has treated the,first patient in its ... prGCD, a proprietary plant cell expressed recombinant form of,human ... storage disorder in humans. The phase III clinical ...
... Acute, Radiation Syndrome or Radiotherapy Adjuvant Likely Targeting Adult ... ... SCOTTSDALE, Ariz., Aug. 27 ImmuneRegen,BioSciences, Inc., a wholly ... today announced that initial studies at,TD2 (TGen Drug Development Services), ...
Cached Medicine Technology:Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD 2Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD 3ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells 2ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells 3ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells 4
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post explaining the ... . , Auto insurance quotes help many drivers find ... necessary to call an agent or visit an agency for ... single website: http://autocarinsurancebest.com/ . , Every business who relies ...
(Date:1/22/2015)... 2015 Carinsurancesavings.biz has released a new blog ... dismemberment insurance . , Purchasing an accidental death and ... advantageous. This type of rider provides benefits if the insured ... considered a lesser form of life insurance. , AD&D ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 A ... Sports Medicine flagship journal Medicine & Science in ... before exercise may help reduce gastrointestinal (GI) problems ... , Participants in the double-blind, placebo-controlled study ...
(Date:1/22/2015)... 2015 Recently, Weddingshe.com has added many trendy ... announced its highest annual revenues in the past three years. ... glamorous wedding dresses. , According to the sales manager of ... promotions for them in 2015. This point can be reflected ...
(Date:1/22/2015)... January 22, 2015 Four years since the release ... which coincided with the marriage of Avasa & Matthew Love – ... which is scheduled for release through White Swan Records on February ... there is a sacred path available to all of us to ...
Breaking Medicine News(10 mins):Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4
... a leading healthcare provider of interim and executive placement and consulting ... of board and CEO services. Formerly vice president, senior executive search, ... roles for hospitals, home care companies, health systems and national healthcare ... ...
... MINNEAPOLIS, Dec. 12 Crossing the finish line ... is a dream that almost didn,t come true for 34 year-old ... the triathlon, which involved a 2.4-mile swim in the Pacific Ocean, ... using a handcycle and a 26.2 mile run that Jason completed ...
... seen, study says , , FRIDAY, Dec. 12 (HealthDay News) -- ... prove to be a valuable new weapon in the crusade ... drug, known as lorcaserin, resulted in substantial weight loss in ... novel mechanism and we think it can bring very robust ...
... idea written on the back of an envelope have the ... Health (SOPH) Dean Max Michael, M.D., talking about the origins ... money grant project for health research. The awards are funded ... an interesting way to allow people to be creative, identify ...
... This morning the Department of Health was notified ... the decision to close the hospital effective today. ... of Health has revoked the hospital,s license. The ... seek emergency treatment since Commonwealth Medical Center is unable ...
... study says , , FRIDAY, Dec. 12 (HealthDay News) -- ... recurrence risk and response to cancer treatment by looking ... a panel of experts report. , The scientists presented ... San Antonio Breast Cancer Symposium in Texas. , Patients ...
Cached Medicine News:Health News:Noland Named Vice President, Board & CEO Services for B. E. Smith 2Health News:Video: Paralyzed From the Chest Down, Triathlete Takes Second in the Handcycle Division of the Ford Ironman World Championship 2Health News:Video: Paralyzed From the Chest Down, Triathlete Takes Second in the Handcycle Division of the Ford Ironman World Championship 3Health News:Video: Paralyzed From the Chest Down, Triathlete Takes Second in the Handcycle Division of the Ford Ironman World Championship 4Health News:Video: Paralyzed From the Chest Down, Triathlete Takes Second in the Handcycle Division of the Ford Ironman World Championship 5Health News:Experimental Weight-Loss Pill Passes Early Test 2Health News:Experimental Weight-Loss Pill Passes Early Test 3Health News:Inaugural Back of the Envelope Awards fund creative health research 2Health News:Progress Made in Predicting Breast Cancer Risk 2Health News:Progress Made in Predicting Breast Cancer Risk 3
Adsons bayonet forceps....
... Medpor Channel Implants, designed to ... the surgeon with an excellent ... wall and floor blowout defects. ... for placement of one or ...
... Rim is designed to augment ... the midface, including the inferior ... positioned in the hollow under ... Rim implant aids in restoring ...
Flattened points in vertical plane, straight shafts, cross action, round handle....
Medicine Products: